Alexia Papanicolas, AUD in Washington, DC - Audiologist

Alexia Papanicolas, AUD is a Audiologist based in Washington, District Of Columbia. Alexia Papanicolas is licensed to practice in District Of Columbia (license number AUD000133) and her current practice location is 1200 1st St Ne, 9th Floor, Washington, District Of Columbia. She can be reached at her office (for appointments etc.) via phone at (202) 442-4800.

NPI number for Alexia Papanicolas is 1053779546 and her current mailing address is 1200 1st St Ne, 9th Floor, Washington, District Of Columbia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1053779546.

Contact Information

	Alexia Papanicolas, AUD
	1200 1st St Ne, 9th Floor, Washington, DC 20002-3361
	(202) 442-4800
	(202) 442-5026

Healthcare Provider's Profile

Full Name	Alexia Papanicolas
Gender	Female
Speciality	Audiologist
Location	1200 1st St Ne, Washington, District Of Columbia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1053779546
Provider Enumeration Date: 01/29/2016
Last Update Date: 01/29/2016

Medical Identifiers

Medical identifiers for Alexia Papanicolas such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1053779546	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	AUD000133 (District Of Columbia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alexia Papanicolas is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Alexia Papanicolas, AUD 1200 1st St Ne, 9th Floor, Washington, DC 20002-3361 Ph: () -	Alexia Papanicolas, AUD 1200 1st St Ne, 9th Floor, Washington, DC 20002-3361 Ph: (202) 442-4800

News Archive

FDA approves Actavis Mixed Amphetamine Salts ER Capsules

Actavis Group, an international generic pharmaceuticals company, today announced that it has received approval from the US Food & Drug Administration to market Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules CII, (hereafter referred to as Mixed Amphetamine Salts ER Capsules), in all available strengths: 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg.

WHO, UNICEF publish plan to reduce childhood diarrhea deaths

The WHO and UNICEF have released a seven-point treatment and prevention plan to reduce the number of children around the world who die from diarrhea, the BBC reports (10/14). BMJ News writes, "Every year 1.5 million children aged under 5 years die from diarrhoea, more than 80% of them in Africa and south Asia" (Zarocostas, 10/14).

Baxter awarded major contract for flu vaccine in the event of a pandemic

Baxter International Inc. has announced that Baxter's European subsidiary in the United Kingdom has entered into an advanced supply agreement with the Department of Health that contains an option to purchase pandemic influenza vaccine in the event the World Health Organization (WHO) declares a pandemic.

Study aims at determining optimal dose of nab-paclitaxel with carboplatin as first-line therapy for NSCLC

The June edition of the Journal of Thoracic Oncology features a study aimed at determining the optimal dose of the chemotherapy drug nab-paclitaxel with carboplatin as a first-line therapy in patients with non-small cell lung cancer. Results will provide researchers with a data needed to guide a phase 3 trial.

24% more children with progeria discovered

Spectrum, a health and science communications firm, announced the results of a global awareness campaign that "found" 24 percent more children identified with a rare, fatal, and rapid aging disease called Progeria. The findings are being shared at a Centers for Disease Control national conference on health communications.

Audiologist in Washington, DC

Sheela L Stuart, PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-5600
Karen Tal Woolman, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5627
Mrs. Elise Ney, M.A, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 4910 Massachusetts Ave Nw, Ste 29, Washington, DC 20016 Phone: 202-362-4300
Ashley King, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2300 M St Nw, Washington, DC 20037 Phone: 410-991-4749
Dr. Claire Bernstein, PH.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 800 Florida Ave Ne, Washington, DC 20002 Phone: 301-509-0722
Hearing 4life Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3301 New Mexico Ave Nw Ste 125, Washington, DC 20016 Phone: 202-621-6374
Kelsey Ann Ambrose, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2300 M St Nw Fl 4, Washington, DC 20037 Phone: 202-741-3275

Alexia Papanicolas, AUD - Audiologist in Washington, DC